To read the full story, subscribe or sign in.

Santhera Starts Phase III Trial In Friedreich's Ataxia Patients

Oct. 1, 2007

By Jim Shrine

BioWorld

Today's news in brief

BioWorld

BioWorld briefs for Nov. 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Nov. 11, 2025.

Drosophila melanogaster (fruit fly) on a blade of grass

Drosophila genetic screening reveals mechanisms behind AD pathology

BioWorld Science

Researchers from the Baylor College of Medicine have characterized 100 conserved Alzheimer’s disease (AD) risk orthologue genes in Drosophila and found several...

Evotec and BMS partnership yields IND approval

BioWorld Science

Evotec SE has received a $5 million milestone payment from Bristol Myers Squibb Co. (BMS), following the acceptance of an IND application by the FDA in the...

NT-0796 ameliorates MASH phenotype in mice

BioWorld Science

There is evidence that NACHT, LRR and PYD domains-containing protein 3 (NLRP3)-driven mechanisms may drive both peripheral and hypothalamic inflammation in...